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Abstract
Interaction of CD4 with MHC class II molecules plays a crucial role during thymlc development
and activation of single-positive CD4 T lymphocytes. The quantltatlon of this Interaction is,
therefore, Important for understanding the role of CD4 during these events. To this end, we have
developed a rosette assay, which enabled us to study this molecular Interaction. By coupling
soluble mouse CD4 onto beads, we could show specific binding of CD4 to MHC class II
molecules on A20 B lymphoma cells. These binding studies revealed an extremely low affinity
(/C, ^ 104 M"1) between CD4 and MHC class II molecules in mouse.
The CD4 co-receptor is expressed on T cells which are MHC
class II restricted and mostly of T helper (Th) cell type (1,2). CD4
is known to bind to a non-polymorphic determinant on MHC class
II (2-6). Interaction of CD4 with MHC class II is crucial during
thymic ontogeny (for review see 7) and plays a dual role in T
cell activation. First, by strengthening the overall interaction
between Th cells and antigen presenting cells (APCs) (8-10),
and, second, by transducing signals to T cells (for review see 11).
The quantitation of this interaction would provide further insights
into the complex interactions occuring in a TCR - CD3 - CD4 -
MHC plus peptide complex during antigen recognition by T cells
and is of specific interest since the affinity of mouse TCR to MHC
class II plus peptide was recently resolved to be about 105 M"1
(12,13).
The direct binding of CD4 and MHC class II has been studied
in the human system (3,6), but no such studies are available for
the corresponding murine molecules. Here, we report the
development of an in vitro assay, with which direct and specific
binding of mouse soluble CD4 (sCD4) to mouse MHC class II
on the cell surface is demonstrated. This assay enabled us to
estimate the affinity of mouse CD4 for MHC class II to be lower
than 104 M"' . This further supports the hypothesis that the role
of CD4 as a co-receptor probably is more important for signal
transduction than adhesion.
To generate soluble CD4 molecules, i.e. CDA-bC/i and
CD4-Cx, Ig expression vectors containing the cDNA for the
extracellular part of the mouse CD4 gene and the C2 - C4 exons
of human /i heavy chain gene or the mouse Cx exon of light chain
genes were transfected into the myeloma cell line J558/L by
protoplast fusion (18,19). Stable transfectants were used for mass
culture. CD4-hC/t was purified from concentrated supernatants
by gel filtration, as described in Fig. 1, and CD4-Cx by using
affinity chromatography (19).
SDS - PAGE analysis of the materials used in this study showed
that chimeric sCD4s of predicted molecular nature were
produced. Non-reducing SDS-PAGE analysis revealed that
CD4-hC/i assembled into a typical pentameric structure of IgM
(Fig. 1), corresponding to a valency of 10 for the CD4 part, while
CD4-Cx behaved as a monomer.
In addition, all tested mAbs (GK1.5 (20); H129 (21); and RM4-4
and RM4-5, both Pharmingen, San Diego, CA) against different
CD4 epitopes recognized the CD4-Qi as well as the CD4-hCx
protein. Reciprocally, antibodies raised against CD4-hC/t and
CD4-Cx stained CD4+ T cells (data not shown). These results
suggest that antigenically native sCD4s are produced. However,
the attempts to detect direct binding of the CD4-hC/i and CD4-Cx
to MHC class II positive cells failed consistently, presumably
because of low affinity.
To test this hypothesis, we further increased the valency of
sCD4 by coupling CD4-hC/i onto beads and performed a rosette
assay by incubating CD4-hC/i- beads with A20 cells, which are
known to express high levels of MHC class II molecules (17).
Subsequently, rosette formation was analysed by microscopy
(Fig. 2). Most of the rosetted cells were completely covered by
CD4-hC/i-beads. To demonstrate that the 'bead-berries' are
rosetted cells and not aggregated beads, cells were stained with
acridine orange, as shown in Fig. 2(A and B).
The rosette formation was specific for the CD4-MHC class
II interaction, since it was completely inhibited by anti-MHC class
II mAb M5/114 (22) (Fig. 2 and Table 1). Irrelevant rat anti-mouse
mAb (53-6.7) as well as an anti-MHC class I mAb (15.5.5s) did
not inhibit rosette formation (summarized in Table 1). M5/114
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Rg. 1. SDS - PAGE analysis of CD4-hQi and CD4-Cx. Purified CD4-hC^,
CD4-C*, and, as a control, human IgM (hlgM) protein were analyzed
by SDS-PAGE. The gels were subsequently stained with coomassie
blue: (A) 7% PA-gel, reducing conditions; (B) 3 - 1 0 % PA-gradient gel;
non-reducing conditions. Standard molecular weight markers are
indicated on the sides. Method: the part of the mouse CD4 (L3T4) cDNA
sequence (14) coding for the extracellular region of the protein was
engineered into Ig expression vectors (15,18) upstream of the C 2 - C 4
exons of the human ^ heavy chain gene or the C exons of the mouse
x light chain gene The resulting constructs pL3T4-hC^ and pL3T4-Cx
(18,19) were introduced into the myeloma cell line J558/L by protoplast
fusion as described (16). Stable transfectants, secreting 2 -6mg/ l
CD4-hC/» were adapted to serum free medium (IMDM, 5 mg/1 insulin,
5 mg/l transferrin, 1 x non-essential amino acids, 0.03% primatone).
CD4-Cx was purified from supernatant with an anti-moose Cx affinity
column and CD4-hC/x was purified from concentrated supernatant by
gel-filtration with a FPLC superose 6 column (Pharmacia, Uppsala,
Sweden).
recognizes an epitope on MHC class II involving 0, and /32
domains (R. Konig, personal communication) and is conserved
in both MHC class II antigens, I-E and I-A. Consistent with this
is the recent finding that part of the CD4 binding site to MHC
class II molecules is located on the p2 domain and that this
binding site must also be conserved in I-E and I-A antigens. We
then tried to carry out further epitope mapping by using a panel
of additional anti-MHC class II mAbs. The mAb MKD6 reacting
with I-A /S, domain (23) and mAb 14.4.4s, recognizing I-Eor as
well as two other mAbs, AMS-16 (anti-l-E) and AMS-32-1 (anti-l-
A), with undefined epitopes were used. None of the I-E- or
Fig. 2. Rosette formation. A20 cells were incubated with
CD4-hC>- beads; subsequently, the cells were stained with acridme
orange The comparison of (A) light micrograph only versus (B) light
micrograph overlaid by fluorescence micrograph reveals that most of
the rosetted A20 cells are completely covered by the beads. (C) Rosette
formation of A20 cells with CD4-hC/i - beads. (D) Complete inhibition of
rosette formation by anti-MHC class II mAb (M5/114, 20 ^ g/ml) (x 400).
Method. CD4-hC/j-beads were prepared by coupling polyclonal anti-
human IgM antibodies (Jackson Immunoresearch, West Grove, PA) onto
tosylactivated Dynabeads M-450 (Dynal, Oslo, Norway) overnight, in
0.5 M borate buffer pH 9.5 at 4°C. Washed Dynabeads were then
incubated with purified CD4-hC/j overnight in PBS/0 1 % BSA at 4°C.
The beads were washed and resuspended in medium (IMDM/5% FCS)
to a concentration of 4 x 1 0 8 beads/ml. The resulting beads
(CD4-hCjt- beads) have thus a layer of CD4, which is oriented to the
outside and has a high density of CD4. For negative controls, anti-human
IgM-beads were loaded the same way with human IgM (Chemicon,
Temecula, CA). The rosette formation assay was performed by mixing
10 ^ l of CD4-hC(i - bead suspension (4 x 10%it) with 50 /J A20 cell (17)
suspension (2x lO^/ml, IMDM/5% FCS), followed by incubation at room
temperature for 1 - 2 h with continuous shaking. To distinguish between
bead-covered cells and aggregated beads, the cells were stained with
acridine orange. Analysis of rosette formation was performed in a
hematocytometer by simultaneous light and fluorescence microscopy.
CeHs with more than five attached beads were counted as rosetted cells.
The percentage of rosetted cells varied from 40 to 90% of total cells
between assays. Anti-human IgM-coupled beads and beads loaded with
human IgM protein were included in each assay as negative controls.
l-A-specific mAbs, nor the combination of I-E- and l-A-specific
mAbs had inhibitory effects on rosette formation at concentrations
up to 250 nM (40 /*g/ml). In contrast, M5/114 inhibited rosette
formation completely at concentrations of 15 nM (2 /xg/ml). Thus,
it seems that only mAb M5/114 binds MHC class II at an epitope
interferring with the interaction of CD4.
Interestingly, although we failed to show direct binding,
Table 1. Specific inhibition of the CD4 - MHC class II interaction
Addition of
None
Rat anU-l-E/l-A
Rat anti-CDS
Mouse anti-H-2K
Mouse anti-l-E
Mouse anti-l-A
Mouse anti-l-E plus
Mouse anti-l-A
CD4-hC^
CD4-C*
Human IgM
Inhibition of
rosette formation
no
completely
no
no
no
no
no
completely
no
no
Reference
—
M5/114 (22)
53-5.7 (30)
15.5.5s (31)
14.4.4s (30) and AMS-16
(Pharmingen)
MKD6 (32) and AMS-32.1
(Pharmingen)
as above
—
—
(Chemtoon)
A20 cells ( H - ^ were preincubated with different antibodies and sCD4
before performing rosette formation assay. Non-blocking antibodies had
concentrations up to 250 nM (40 /ig/mf), except human IgM and CD4-C*,
where concentrations up to 2 mg/ml respectively did not inhibit rosette
formation.
ID
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o
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o
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Inhibitor [M]
Rg. 3. Inhibition assay of rosette formation. A20 cells were preincubated
with serial dilutions of anti-MHC class II mAbs (M5/114), CD4-hC^ or
CD4-Cx before addition of CD4-hC/j- beads for the rosette formation
assay. The arrow indicates the endpoint of CD4-Cx titration. Inhibition
was standardized to rosette formation without any inhibitor (0%). A typical
example of such an inhibition assay is presented here. Variation between
assays was very small.
CD4-hC/i completely inhibited rosette formation, most likely
because no washing steps are needed for specific rosette
formation. Control human IgM did not inhibit rosette formation,
indicating that binding of CD4-hC/x - beads to A20 cells is
mediated by the CD4 part of the chimeric molecule. Complete
inhibition of rosette formation by CD4-hC/j was obtained at
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concentrations of about 4 /zM. Importantly, a monovalent form
of CD4, CD4-C*, was not observed to inhibit the rosette formation
at up to 100 iiM (4 mg/ml). We attribute these findings to the
increased avidity of the pentameric CD4-hC^, due to its
multivalency compared with monovalent CD4-C*. In fact, the
pioneering work of Karush has shown that multivalency of IgM
can increase the avidity up to 107-fold compared with
monovalent affinity (24).
The concentration values needed for 50% inhibition of the
rosette formation can be used to estimate the affinity or avidity
of an inhibitor (Fig. 3). This is illustrated by the fact that bivalent
M5/114 mAb inhibits 50% of the rosette formation at about
5x 10~9 M (Fig. 3), the value, which corresponds exactly to the
avidity of the bivalent antibody measured by classical Scatchard
analyses, Ka - 5 X 1 0 9 M"1 (21 and our unpublished results).
Thus, the avidity of CD4-hC/» is estimated to be about 7x 107
M~\ since a 100-fold higher concentration of CD4-hC/* is
needed for inhibition of rosette formation compared with M5/114.
Since extrapolation of affinities from avidity values is not possible
(24), we can confidently estimate the upper limit for Ke to be 104
M"' or below from the fact that the monovalent form of sCD4
did not inhibit rosette formation at concentrations of 100 /iM
(10"4 M). This value is in agreement with more indirect
estimates of Hussey etal. (24) in the human system, but much
lower than the affinity (KB = 3x10 6 M"1) measured by
Cammarota etal. (6), again for the human CD4-MHC class II
interaction. The latter authors used both sCD4 and soluble MHC
class II molecules to derive their affinity values, and it is
conceivable that soluble MHC class II molecules are more
accessible to sCD4 than MHC class II molecules embedded in
the membrane. This may also explain why human sCD4 has
never been shown directly to bind MHC class II positive cells.
CD4 has been proposed to have two different roles in antigen-
specific interaction between Th cells and APCs: firstly, CD4 as
an accessory molecule is thought to contribute to the general
adhesion between Th cells and APCs (8-10), and, secondly,
CD4 as a co-receptor for TCR has been suggested to be essential
for optimal Th cell activation, due to its signal transducing
capabilities (for review, see 11). Based on our results, we think
that CD4 makes only a very minor contribution to the general
adhesion, since the other adhesion systems used by Th cells,
like CD2/LFA-3 and LFA-1/ICAM, have affinities of at least two
orders of magnitude higher than that of CD4/MHC class II
molecules (26). Therefore, we reason that the co-receptor function
is most likely physiologically more significant. Interestingly, it has
been shown that CD4 can associate with TCR complexes
(27-29) and thus, presumably, it has some affinity to the TCR
complex as well. Therefore, due to this dual binding specificity
of CD4, it may exhibit much higher affinity to the TCR-CD3-
MHC plus peptide complex, as opposed to its affinities to either
TCR-CD3 or MHC class II molecules alone. This would also
explain why the CD4, as a signalling molecule during T cell
activation, can find its relevant partner in the presence of an
excess of potentially irrelevant MHC class II and TCR molecules.
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